🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to evaluate safety and effectiveness of Ilaris in adult and...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-03-29
Trial ID
NCT06838143
Treatments Being Tested
This was a four month dose ranging study followed by a 24 to 48 month exten...
Status
Terminated
Location
Anasazi Internal Medicine
Start Date
2009-04
Trial ID
NCT00900146
Treatments Being Tested
This study is a multi-institution, open-label, Phase 1b/2 clinical trial ev...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2021-03-30
Trial ID
NCT04798339
Treatments Being Tested
This was a phase III study designed to provide efficacy and safety data for...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-07
Trial ID
NCT02396212
Treatments Being Tested
This study will evaluate safety, tolerability, pharmacokinetics and pharmac...
Status
Completed
Location
Novartis Investigative site
Start Date
2006-12
Trial ID
NCT00421226
Treatments Being Tested
This 8-week study is designed to determine the target dose of canakinumab (...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2008-11
Trial ID
NCT00798369
Treatments Being Tested
The purpose of this study is to evaluate the effects of IL-1β inhibition on...
Status
Completed
Location
San Francisco General Hospital
Start Date
2015-09
Trial ID
NCT02272946
Treatments Being Tested
This study is to determine whether canakinumab is able to induce and mainta...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-06-27
Trial ID
NCT02059291
Treatments Being Tested
The COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a m...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-11-15
Trial ID
NCT05080218
This trial will assess the safety and efficacy of ACZ885 in patients with a...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-10
Trial ID
NCT01242813
Treatments Being Tested